… on non-corticosteroid bronchodilators compared to the control … would benefit from regular
monitoring of their ocular health. … association of inhaled corticosteroids and increased risk of …

… Clinical features to look out for in the high-risk eye are pre… are frequently treated with
bronchodilator medications. These … However, it has been suggested that nebulized administration …

… risk of serious exacerbations 1 . In contrast, there is much debate about the role of ICS relative
to long-acting inhaled bronchodilators, … bruising, as well as ocular adverse effects such as …

… to improve the delivery of albuterol sulphate. They concluded that … nebulization, visual
inspection of the ‘cloud of nebulization’ … diffusion of nebulized colistin, the risk of nephrotoxicity is …

… risk of acute angle glaucoma secondary to topical deposition on the eye of nebulized
bronchodilators… humor out of the anterior chamber of the eye. In subjects predisposed to angle-…

… which included mydriatic eye drops containing phenylephrine… In this report, we highlight the
potential risk of reversible … , antihistamines, and inhaled bronchodilators. We were unable to …

… the risk of exacerbations. Citation2 As a result, long-acting bronchodilators with or without
inhaled … therapy (eg, patients with low PIFR, the elderly, and those with cognitive or visual …

… We assessed the risk of bias using a domain-based evaluation, classifying studies primarily
… , including bronchodilators, epinephrine, or no medication. Inhaled bronchodilators and …

… , 100% oxygen, and inhaled bronchodilators for bronchospasm. The physical examination
… , is extremely hazardous to the eyes. Therefore, following ocular irrigation in symptomatic …

… in terms ECOPD risk reduction [130, 137], we would support the addition of ICS to long-acting
bronchodilator therapy in those patients who still experience ECOPD despite appropriate …